Alterations in Infant Gut Microbiota Precede Development of Eczema
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, Sept. 5, 2023 -- The gut microbiome may play a role in development of eczema in infancy, according to a study published online Aug. 30 in mSystems.
Man Kit Cheung, Ph.D., from the Chinese University of Hong Kong, and colleagues characterized the development and determinants of the gut microbiome in a prospective cohort of 112 term Chinese children. The analysis included results from sequencing 713 stool samples collected at nine time points from birth to 3 years using 16S rRNA gene sequencing.
The researchers identified mode of delivery, feeding mode, and intrapartum antibiotics as the major determinants of the early-life gut microbiome, the effects of which persisted up to 12 months. Alterations in the infant gut microbiota preceded the development of eczema, including a depletion of Bacteroides and an enrichment of Clostridium sensu stricto 1 in the gut microbiome of infants with eczema at 1 year old. Similar patterns were seen in Cesarean section-born infants within the same time frames, suggesting a role of the gut microbiota in previously reported associations between Cesarean section and an increased risk for eczema.
“The first year of life could be a critical period to restore the gut bacteria to a more desirable composition,” the study’s principal investigator, Paul Chan, M.D., also from the Chinese University of Hong Kong, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Stigma Affects Quality of Life in Children With Chronic Skin Conditions
TUESDAY, April 30, 2024 -- Health care professionals should consider stigmatization and bullying in assessing the social and mental health of children and adolescents with chronic...
AAD: Lebrikizumab Shows Efficacy in Skin-of-Color Patients With Atopic Dermatitis
MONDAY, March 18, 2024 -- Lebrikizumab demonstrates improvement in skin clearance and itch relief in patients with skin of color and moderate-to-severe atopic dermatitis...
Atopic Dermatitis in Children Tied to Learning, Memory Difficulties
TUESDAY, March 12, 2024 -- Pediatric atopic dermatitis (AD) is associated with greater odds of reported difficulties in learning and memory, but this association is driven by...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.